METHYL (2S,4S)-4-(5-ISOPROPYL-2-METHYLPHENOXY)-2-PYRROLIDINECARBOXYLATE
- $205 - $412.65
- Product name: METHYL (2S,4S)-4-(5-ISOPROPYL-2-METHYLPHENOXY)-2-PYRROLIDINECARBOXYLATE
- CAS: 1217791-17-7
- MF: C16H23NO3
- MW: 277.36
- EINECS:
- MDL Number:MFCD08688248
- Synonyms:METHYL (2S,4S)-4-(5-ISOPROPYL-2-METHYLPHENOXY)-2-PYRROLIDINECARBOXYLATE;D-Proline, 4-[2-methyl-5-(1-methylethyl)phenoxy]-, methyl ester, (R,4R)-rel-
3 prices
Selected condition:
Brand
- AK Scientific
- American Custom Chemicals Corporation
- Matrix Scientific
Package
- 500mg
- ManufacturerAK Scientific
- Product number1313AD
- Product descriptionMethyl(2S,4S)-4-(5-isopropyl-2-methylphenoxy)-2-pyrrolidinecarboxylate
- Packaging500mg
- Price$326
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCCH0005182
- Product descriptionMETHYL-(2S,4S)-4-(5-ISOPROPYL-2-METHYLPHENOXY)-2-PYRROLIDINECARBOXYLATE 95.00%
- Packaging500MG
- Price$412.65
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number023636
- Product descriptionMethyl (2S,4S)-4-(5-isopropyl-2-methylphenoxy)-2-pyrrolidinecarboxylate
- Packaging500mg
- Price$205
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 1313AD | Methyl(2S,4S)-4-(5-isopropyl-2-methylphenoxy)-2-pyrrolidinecarboxylate | 500mg | $326 | 2021-12-16 | Buy |
American Custom Chemicals Corporation | CCH0005182 | METHYL-(2S,4S)-4-(5-ISOPROPYL-2-METHYLPHENOXY)-2-PYRROLIDINECARBOXYLATE 95.00% | 500MG | $412.65 | 2021-12-16 | Buy |
Matrix Scientific | 023636 | Methyl (2S,4S)-4-(5-isopropyl-2-methylphenoxy)-2-pyrrolidinecarboxylate | 500mg | $205 | 2021-12-16 | Buy |
Properties
Boiling point :373.0±42.0 °C(Predicted)
Density :1.074±0.06 g/cm3(Predicted)
pka :7.11±0.10(Predicted)
Density :1.074±0.06 g/cm3(Predicted)
pka :7.11±0.10(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|